Abstract:

The present invention relates to the use of pomegranate seed oil and fractions thereof for preventing and treating neurodegenerative diseases. Particularly, the present invention relates to emulsions of the pomegranate oil or fractions thereof for the prevention and treatment of brain diseases, including Creutzfeldt-Jacob disease (CJD) and multiple sclerosis (MS). The pomegranate seed oil or fraction thereof is administered in a form of an emulsion as a medical food, a functional food, a food additive, or a dietary supplement. A self-emulsifying drug delivery system (SEDDS) comprising pomegranate seed oil 31.46%, Tween 80 44%, Span 80 19.5%, and ethanol 4.97% was exemplified. Also, pomegranate oil and punicic acid significantly inhibited the toxic effect of copper in a transgenic mouse model of genetic prion disease, as measured by elevated percentage of cell survival. [on SciFinder(R)]

Notes:

CAPLUS AN 2013:1698216(Patent)